Align Technology | ALGN - Ebitda

Stock Price
164.23
Daily Change
-2.69 -1.61%
Monthly
-12.28%
Yearly
-1.19%
Q1 Forecast
159.27

Align Technology reported $183.84M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
3M USD 1.68B 227M Sep/2025
Align Technology USD 183.84M 19.77M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bruker USD 211.6M 207.4M Dec/2025
Cardinal Health USD 981M 5M Dec/2025
Charles River Laboratories USD 258.06M 24.83M Dec/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
CVS Health USD 3.74B 349M Dec/2025
Danaher USD 2.13B 252M Dec/2025
Dentsply International USD 135M 32M Dec/2025
Dexcom USD 422.2M 53.8M Dec/2025
Henry Schein USD 291M 4M Dec/2025
Idexx Laboratories USD 391.47M 17.97M Sep/2025
Insulet USD 194M 34M Dec/2025
Integra LifeSciences USD 104.21M 25.76M Dec/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
Masimo USD 91.9M 19.9M Sep/2025
McKesson USD 1.68B 418M Sep/2025
Mettler Toledo International USD 322.64M 26.75M Sep/2025
Revvity USD 248.91M 48.52M Dec/2025
Solventum Corp USD 437M 38M Dec/2025
Stryker USD 1.67B 206M Sep/2025
Teleflex USD -328.81M 536.43M Sep/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Veeva Systems USD 374.79M 3.96M Dec/2025
Waters USD 380.97M 85.83M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025
Zoetis USD 1.04B 87M Sep/2025